India at point where we can expect vaccine in few days: Govt
By IANS |
Published on
Tue, Dec 29 2020 17:42 IST |
0 Views
Serum Institute-Oxford s Covishield, Bharat Biotech s Covaxin and Pfizer vaccine are in the fray for emergency use authorisation. Image Source: IANS News
New Delhi, Dec 29 : As India eagerly awaits the regulatory approval for the coronavirus vaccine, a senior government official on Tuesday said that the country is at a point where the silver bullet can be expected in a few days .
Addressing a press conference, Dr V.K. Paul, Member (Health), Niti Aayog said: We are that point where we can expect vaccine in few days. We have to move forward with optimism. We expect that coming days will be better.
SII expects nod for Covid-19 vaccine in few days daijiworld.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from daijiworld.com Daily Mail and Mail on Sunday newspapers.
India launches first fully indigenous pneumococcal vaccine Filed on December 28, 2020
Alamy
Serum Institute is also testing and producing the Oxford-AstraZeneca Covid-19 vaccine in India
Pune-based Serum Institute of India, the largest vaccine manufacturer in the world by doses, on Monday announced the launch of India s first indigenously developed pneumococcal vaccine - Pneumosil - in the presence of Union Health Minister Harsh Vardhan.
Pneumosil has been developed through collaboration spanning over a decade among the Serum Institute, PATH and the Bill and Melinda Gates Foundation. This significant milestone is aimed at improving pneumococcal conjugate vaccine affordability and enabling sustainable access for low-and middle-income countries.
NEW DELHI: Pune-based Serum Institute of India (SII) has submitted additional updated data from clinical trials of Covishield sought by the drug regulator’s panel evaluating Covid vaccine applications for emergency use authorisation, official sources said, reports Sushmi Dey.
The Subject Expert Committee (SEC) on Covid vaccine under the Drugs Controller General of India had asked Bharat Biotech and SII to produce updated data from ongoing clinical trials in India.
The latest development may once again set the clock ticking for the launch of the vaccine, as the government is expecting to roll out vaccination against Covid-19 by mid-January.
FacebookTwitterLinkedinEMail